The SIDER database of drugs and side effects

Unwanted side effects of drugs are a burden on patients and a severe impediment in the development of new drugs. At the same time, adverse drug reactions (ADRs) recorded during clinical trials are an important source of human phenotypic data. It is therefore essential to combine data on drugs, targets and side effects into a more complete picture of the therapeutic mechanism of actions of drugs and the ways in which they cause adverse reactions. To this end, we have created the SIDER (‘Side Effect Resource’, http://sideeffects.embl.de) database of drugs and ADRs. The current release, SIDER 4, contains data on 1430 drugs, 5880 ADRs and 140 064 drug–ADR pairs, which is an increase of 40% compared to the previous version. For more fine-grained analyses, we extracted the frequency with which side effects occur from the package inserts. This information is available for 39% of drug–ADR pairs, 19% of which can be compared to the frequency under placebo treatment. SIDER furthermore contains a data set of drug indications, extracted from the package inserts using Natural Language Processing. These drug indications are used to reduce the rate of false positives by identifying medical terms that do not correspond to ADRs.

[1]  Luca Toldo,et al.  Extraction of potential adverse drug events from medical case reports , 2012, Journal of biomedical semantics.

[2]  Michael Kuhn,et al.  Reflect: augmented browsing for the life scientist , 2009, Nature Biotechnology.

[3]  Quan Xu,et al.  ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms , 2014, Nucleic Acids Res..

[4]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[5]  Thomas Joseph,et al.  A pipeline to extract drug-adverse event pairs from multiple data sources , 2014, BMC Medical Informatics and Decision Making.

[6]  Rong Xu,et al.  Automatic construction of a large-scale and accurate drug-side-effect association knowledge base from biomedical literature , 2014, J. Biomed. Informatics.

[7]  L. Jensen,et al.  The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text , 2013, PloS one.

[8]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[9]  Patrick Aloy,et al.  Analysis of chemical and biological features yields mechanistic insights into drug side effects. , 2013, Chemistry & biology.

[10]  Patrick Aloy,et al.  IntSide: a web server for the chemical and biological examination of drug side effects , 2014, Bioinform..

[11]  Damian Szklarczyk,et al.  STITCH 4: integration of protein–chemical interactions with user data , 2013, Nucleic Acids Res..

[12]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[13]  Aarash Bordbar,et al.  Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis , 2015, Nature Communications.

[14]  Russ B. Altman,et al.  Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach , 2015, J. Chem. Inf. Model..

[15]  R. Sharan,et al.  PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.

[16]  Christopher D. Manning,et al.  The Stanford Typed Dependencies Representation , 2008, CF+CDPE@COLING.

[17]  P. Bork,et al.  Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.

[18]  T. Werge,et al.  Dose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric Population , 2014, Drug Safety.